Transformative mutation specific pharmacotherapy for cystic fibrosis.
Don B
DB
Sanders
Philip M
PM
Farrell
D000627:Aminophenols / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D005541:Forced Expiratory Volume; D006801:Humans; D009154:Mutation; D015363:Quinolones / Q000627:therapeutic use*
D000627:Aminophenols; D015363:Quinolones; C545203:ivacaftor